BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · IEX Real-Time Price · USD
1.660
-0.010 (-0.60%)
Jul 22, 2024, 9:45 AM EDT - Market open
BioRestorative Therapies Employees
BioRestorative Therapies had 11 employees as of December 31, 2023. The number of employees increased by 1 or 10.00% compared to the previous year.
Employees
11
Change (1Y)
1
Growth (1Y)
10.00%
Revenue / Employee
$13,591
Profits / Employee
-$632,431
Market Cap
11.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Mustang Bio | 80 |
RedHill Biopharma | 53 |
Senti Biosciences | 48 |
Calidi Biotherapeutics | 41 |
Vaccinex | 40 |
Dominari Holdings | 28 |
Traws Pharma | 18 |
Cardio Diagnostics Holdings | 9 |
BRTX News
- 25 days ago - BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program - GlobeNewsWire
- 5 weeks ago - BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program - GlobeNewsWire
- 6 weeks ago - BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference - GlobeNewsWire
- 2 months ago - BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice - GlobeNewsWire
- 2 months ago - BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market - Accesswire
- 2 months ago - BioRestorative Therapies Provides First Quarter 2024 Business Update - GlobeNewsWire
- 2 months ago - BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity - GlobeNewsWire